EGF and neoplasm: Classification of breast cancer (BC) has been historically based on both analysis of tumor morphology and histological detection of three marker proteins: the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor (EGF) receptor tyrosine kinase 2 (ErbB2 or HER2).